Trial intelligence / Profile preview

RTS,S Malaria Vaccine Human Challenge Study

NCT00075049Phase 2Completed

Sponsor
U.S. Army Medical Research and Development Command
Start
Dec 2003
Primary completion
Jan 2006
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of RTS,S in malaria (2 arms), sponsored by U.S. Army Medical Research and Development Command. Primary endpoint: Safety and reactogenicity of the candidate vaccine. Started Dec 2003; status: completed.

02

Drugs

RTS,S
03

Conditions

malaria

Beyond the preview

Go deeper on NCT00075049.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00075049.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call